403
Sorry!!
Error! We're sorry, but the page you were looking for doesn't exist.
Briacell Therapeutics Corp.
(MENAFN- Baystreet) 10:26 AM EST - BriaCell Therapeutics Corp.: Today announced that four abstracts featuring preclinical research from their respective immunotherapy programs have been selected for poster presentations at the Society for Immunotherapy of Cancer (SITC) 41th Anniversary Annual Meeting, taking place November 4-8, in Phoenix. BriaCell Therapeutics Corp.
shares T are trading down $0.01 at $5.92.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept any
responsibility or liability for the accuracy, content, images, videos,
licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright issues
related to this article, kindly contact the provider above.
Comments
No comment